Fisher & Paykel Healthcare Corporation Limited (FPH.NZ)
NZD 33.45
(-3.27%)
NZD 33.45
(-3.27%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 368.2 Million NZD | -15.1% |
| 2023 | 433.7 Million NZD | -28.33% |
| 2022 | 605.1 Million NZD | -25.13% |
| 2021 | 808.2 Million NZD | 85.62% |
| 2020 | 435.4 Million NZD | 28.97% |
| 2019 | 337.6 Million AUD | 6.8% |
| 2018 | 316.1 Million AUD | 12.48% |
| 2017 | 281.02 Million AUD | 14.06% |
| 2016 | 246.38 Million AUD | 22.05% |
| 2015 | 201.87 Million AUD | 15.8% |
| 2014 | 174.33 Million AUD | 23.91% |
| 2013 | 140.69 Million AUD | 18.03% |
| 2012 | 119.2 Million AUD | -0.99% |
| 2011 | 120.39 Million AUD | -0.46% |
| 2010 | 120.94 Million AUD | -0.01% |
| 2009 | 120.95 Million AUD | 62.7% |
| 2008 | 74.34 Million AUD | -28.29% |
| 2007 | 103.68 Million AUD | -9.65% |
| 2006 | 114.76 Million AUD | 13.91% |
| 2005 | 100.74 Million AUD | 12.24% |
| 2004 | 89.76 Million AUD | -25.27% |
| 2003 | 120.11 Million AUD | 17.87% |
| 2002 | 101.9 Million AUD | 310.39% |
| 2001 | 24.83 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 123.2 Million NZD | 0.0% |
| 2024 FY | - NZD | 11.37% |
| 2024 Q2 | 219.1 Million NZD | 105.34% |
| 2024 Q1 | 99.2 Million NZD | -62.94% |
| 2024 Q3 | 123.2 Million NZD | -39.52% |
| 2023 Q3 | 120 Million NZD | -33.74% |
| 2023 FY | - NZD | -28.33% |
| 2023 Q4 | 257.6 Million NZD | 114.67% |
| 2023 Q2 | 181.1 Million NZD | 136.23% |
| 2023 Q1 | 76.66 Million NZD | -67.28% |
| 2022 FY | - NZD | -25.13% |
| 2022 Q1 | 159.25 Million NZD | -62.76% |
| 2022 Q4 | 234.3 Million NZD | 110.04% |
| 2022 Q2 | 328 Million NZD | 105.96% |
| 2022 Q3 | 111.55 Million NZD | -65.99% |
| 2021 Q4 | 427.7 Million NZD | 108.24% |
| 2021 Q2 | 346.6 Million NZD | 117.12% |
| 2021 Q1 | 159.63 Million NZD | -36.68% |
| 2021 FY | - NZD | 85.62% |
| 2021 Q3 | 205.38 Million NZD | -40.74% |
| 2020 Q2 | 197.9 Million NZD | 117.93% |
| 2020 Q3 | 113.12 Million NZD | -42.84% |
| 2020 FY | - NZD | 28.97% |
| 2020 Q1 | 90.8 Million NZD | 1.7% |
| 2020 Q4 | 252.1 Million NZD | 122.84% |
| 2019 Q3 | 88.71 Million NZD | 15.44% |
| 2019 Q2 | 76.85 Million NZD | 0.22% |
| 2019 Q1 | 76.68 Million NZD | -5.48% |
| 2019 FY | - AUD | 6.8% |
| 2019 Q4 | 89.28 Million NZD | 0.64% |
| 2018 FY | - AUD | 12.48% |
| 2018 Q4 | 81.13 Million NZD | 3.71% |
| 2018 Q3 | 78.23 Million NZD | 22.67% |
| 2018 Q2 | 63.77 Million NZD | -3.41% |
| 2018 Q1 | 66.02 Million NZD | -0.95% |
| 2017 FY | - AUD | 14.06% |
| 2017 Q4 | 66.66 Million NZD | -4.7% |
| 2017 Q1 | 62.49 Million NZD | 4.86% |
| 2017 Q2 | 62.12 Million NZD | -0.59% |
| 2017 Q3 | 69.94 Million NZD | 12.58% |
| 2016 Q1 | 49.1 Million NZD | -10.44% |
| 2016 FY | - AUD | 22.05% |
| 2016 Q4 | 59.59 Million NZD | -4.17% |
| 2016 Q3 | 62.19 Million NZD | 22.52% |
| 2016 Q2 | 50.76 Million NZD | 3.37% |
| 2015 Q4 | 54.83 Million NZD | 2.97% |
| 2015 Q3 | 53.25 Million NZD | 35.39% |
| 2015 Q1 | 40.98 Million NZD | -3.2% |
| 2015 FY | - AUD | 15.8% |
| 2015 Q2 | 39.33 Million NZD | -4.04% |
| 2014 FY | - AUD | 23.91% |
| 2014 Q4 | 42.33 Million NZD | 1.63% |
| 2014 Q3 | 41.65 Million NZD | 14.94% |
| 2014 Q2 | 36.24 Million NZD | 5.38% |
| 2014 Q1 | 34.39 Million NZD | 10.82% |
| 2013 FY | - AUD | 18.03% |
| 2013 Q4 | 31.03 Million NZD | 1.05% |
| 2013 Q3 | 30.71 Million NZD | 0.0% |
| 2012 FY | - AUD | -0.99% |
| 2011 FY | - AUD | -0.46% |
| 2010 FY | - AUD | -0.01% |
| 2009 FY | - AUD | 62.7% |
| 2008 FY | - AUD | -28.29% |
| 2007 FY | - AUD | -9.65% |
| 2006 FY | - AUD | 13.91% |
| 2005 FY | - AUD | 12.24% |
| 2004 FY | - AUD | -25.27% |
| 2003 FY | - AUD | 17.87% |
| 2002 FY | - AUD | 310.39% |
| 2001 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|